Durable clinical response to crizotinib in IRF2BP2-NRTK1 non-small cell lung cancer

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Durable clinical response to crizotinib in IRF2BP2-NRTK1 non-small cell lung cancer
Authors
Keywords
Crizotinib, IRF2BP2, NSCLC, NTRK, fusion, Pan-TRK inhibitor
Journal
Clinical Lung Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-01-01
DOI
10.1016/j.cllc.2018.12.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.